A hand points toward a colorful molecular surface rendering on a presentation slide, with a green molecular structure embedded among red, blue, and white atom-like shapes; part of a chart and labels are visible at left.
March 19, 2012

Next My Health Chat to explore cancer drug discovery

Two gray DNA double-helix models, one fragmented, with red molecular components scattered between them on a white background.
March 2, 2012

‘Detangler’ binds, bends and cuts DNA

New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.

Nashville Predators hockey team logo: a stylized saber-toothed tiger in navy, gold, and white, with a small trademark symbol below.
February 3, 2012

Help put childhood cancer on ice at Predators game March 10

Presentation slide titled “What makes cancer cancer?” with the heading “First things first: Normal Cell Division” and a bullet stating, “Your body is made up of trillions of cells, the basic units of life.”
February 2, 2012

Dr. Michael Neuss: “How much progress has been made in the fight against cancer?”

Close-up of a middle-aged man’s eyes, forehead, eyebrows, and upper nose, with a dark spot visible on his forehead.
January 26, 2012

Investigators seek clues to resistance to melanoma drug

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.

Stylized green molecular model beside blue DNA double-helix structures.
January 25, 2012

Protein repairs esophageal DNA damage

A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer.